MAPS PBC

AMA's Reimbursement Codes For Psychedelic-Assisted Therapies Take Effect: Here's What To Expect
Could MDMA Revolutionize PTSD Treatment? In Historic Move, FDA Considers New Drug Application
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
Could MDMA Revolutionize PTSD Treatment? In Historic Move, FDA Considers New Drug Application
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next
Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures

MAPS PBC Recent News

MDMA Therapy For Chronic PTSD: Neuroimaging With Veterans & First Responders Provides Further Evidence
The legendary non-profit’s private arm, MAPS Public Benefit Corporation (MAPS PBC), announced that Frontiers in Psychiatry has published its first functional neuroimaging study evaluating how MDMA-assisted therapy work
Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More
Guess Which East Coast State Is Now Discussing Legalizing Psychedelics? Decriminalizing psychedelics is one thing, but fully legalizing them is another. That's currently a measure before New York's Senate Health Committee.
MDMA For PTSD Shows Positive Results In Important Clinical Trial: Are Psychedelic Treatments Around The Corner?
MAPS Public Benefit Corporation (MAPS PBC), the non-profit’s private biopharma leg developing psychedelic medicines, announced positive results from MAPP2, the company’s second Phase 3 study assessing MDMA-assisted therap
MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD, Topline Data & New Drug Application Next
MAPS Public Benefit Corporation (PBC) announced the final participant’s last Evaluation and Exit Planning therapeutic session was completed in MAPP2, a multi-site Phase 3 study of MDMA-assisted therapy for the treatment of Post-Traumatic Stress Disorder (PTSD.)
Can Psychedelics Therapy Training Become A Profitable Business? We Asked Industry Insiders
Demand for specialized therapists capable of providing psychedelics-assisted treatments is expected to continue growing. At the same time, the number of people willing to get trained is expanding.